Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
Pediatric Blood & Cancer
|
October 19, 2023
Busulfan and subsequent malignancy: An evidence-based risk assessment
Janel R Long-Boyle, Donald B Kohn, Ami J Shah, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2021
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
Linlin Yang, Claire Booth, Carsten Speckmann, et al.
Molecular Therapy. Methods & Clinical Development
|
July 1, 2024
Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy
Stuart Ellison, Karen Buckland, Yuko Learmonth, et al.
The Journal of Allergy and Clinical Immunology
|
January 23, 2018
T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations
Sujal Ghosh, Marlene Carmo, Miguel Calero-Garcia, et al.
The Lancet. Child & Adolescent Health
|
August 13, 2022
Regenerative medicine: postnatal approaches
Paul Kwong Hang Tam, Kenneth Kak Yuen Wong, Anthony Atala, et al.
The Journal of Allergy and Clinical Immunology. Global
|
April 21, 2026
International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysis
Jennifer Heimall, Luis Ignacio González-Granado, Claire Booth, et al.
Journal of Clinical Immunology
|
April 21, 2020
Urogenital Abnormalities in Adenosine Deaminase Deficiency
Roberta Pajno, Lucia Pacillo, Salvatore Recupero, et al.
Plos Biology
|
November 10, 2011
Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP
Umaimainthan Palendira, Carol Low, Anna Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 29, 2024
Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant
Jenny Yeung, Aiyin Liao, Matthew Shaw, et al.
The Journal of Allergy and Clinical Immunology
|
March 13, 2024
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia
Sameer Bahal, Marta Zinicola, Shefta E Moula, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
Pediatric Blood & Cancer
|
October 19, 2023
Busulfan and subsequent malignancy: An evidence-based risk assessment
Janel R Long-Boyle, Donald B Kohn, Ami J Shah, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2021
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
Linlin Yang, Claire Booth, Carsten Speckmann, et al.
Molecular Therapy. Methods & Clinical Development
|
July 1, 2024
Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy
Stuart Ellison, Karen Buckland, Yuko Learmonth, et al.
The Journal of Allergy and Clinical Immunology
|
January 23, 2018
T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations
Sujal Ghosh, Marlene Carmo, Miguel Calero-Garcia, et al.
The Lancet. Child & Adolescent Health
|
August 13, 2022
Regenerative medicine: postnatal approaches
Paul Kwong Hang Tam, Kenneth Kak Yuen Wong, Anthony Atala, et al.
The Journal of Allergy and Clinical Immunology. Global
|
April 21, 2026
International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysis
Jennifer Heimall, Luis Ignacio González-Granado, Claire Booth, et al.
Journal of Clinical Immunology
|
April 21, 2020
Urogenital Abnormalities in Adenosine Deaminase Deficiency
Roberta Pajno, Lucia Pacillo, Salvatore Recupero, et al.
Plos Biology
|
November 10, 2011
Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP
Umaimainthan Palendira, Carol Low, Anna Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 29, 2024
Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant
Jenny Yeung, Aiyin Liao, Matthew Shaw, et al.
The Journal of Allergy and Clinical Immunology
|
March 13, 2024
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia
Sameer Bahal, Marta Zinicola, Shefta E Moula, et al.
Page
of 9